STOCK TITAN

Lifevantage (LFVN) director discloses stock gift to family trust

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lifevantage Corp director Michael Beindorff reported gifting company stock to a family trust. On 11/25/2025, he transferred 7,819 shares of Lifevantage common stock in a transaction coded "G," which indicates a gift with a reported price of $0 per share.

After this transaction, he directly owned 27,570 shares and indirectly held 51,625 shares through the Michael A. Beindorff Trust, where he and his spouse are trustees. Additional indirect holdings include 126 shares held by his spouse as custodian for minor children and 5,500 shares held by his spouse.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BEINDORFF MICHAEL A

(Last) (First) (Middle)
3300 TRIUMPH BLVD, SUITE 700

(Street)
LEHI UT 84043

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/25/2025 G 7,819 D $0 27,570 D
Common Stock 11/25/2025 G 7,819 A $0 51,625 I By Trust(1)
Common Stock 126 I By Spouse as Custodian for Minor Children
Common Stock 5,500 I By Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares are held by the Michael A. Beindorff Trust U/A DTD 06/14/2000 of which the reporting person and his spouse are trustees.
Remarks:
/s/ Alissa Neufeld, Power of Attorney for Michael Beindorff 12/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Lifevantage (LFVN) report in this Form 4?

The filing reports that director Michael Beindorff completed a transaction coded "G" (a gift) involving 7,819 shares of Lifevantage common stock on 11/25/2025 at a reported price of $0 per share.

How many Lifevantage (LFVN) shares does Michael Beindorff own directly after the transaction?

Following the reported gift transaction, Michael Beindorff directly owned 27,570 shares of Lifevantage common stock.

What are Michael Beindorffs indirect holdings of Lifevantage (LFVN) shares?

Indirectly, Michael Beindorff holds 51,625 shares through the Michael A. Beindorff Trust, 126 shares held by his spouse as custodian for minor children, and 5,500 shares held by his spouse.

What is the nature of the trust holding Lifevantage (LFVN) shares for Michael Beindorff?

The 51,625 shares are held by the Michael A. Beindorff Trust U/A DTD 06/14/2000, for which the reporting person and his spouse serve as trustees.

What is Michael Beindorffs relationship to Lifevantage (LFVN)?

Michael Beindorff is listed as a Director of Lifevantage Corp in the filing.

Is the reported Lifevantage (LFVN) Form 4 filed for one or multiple reporting persons?

The document indicates that the Form 4 is filed by one reporting person, referring to Michael Beindorff.

Lifevantage Corp

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data

70.49M
10.48M
16.79%
65.65%
19.95%
Packaged Foods
Pharmaceutical Preparations
Link
United States
LEHI